Innovation
16 patent families (5 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace steady. Cited 875 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 2 |
Social engagement
Social engagement: 1.6K social following, 5 posts in the last 12 months — top 10% of its industry.
Investor mix
16 investors on record; lead investors include Esperante, Catalio Capital Management, Camden Partners, Humboldt Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 38% |
| Private equity | 3 | 19% |
| Angel & family office | 1 | 6% |
| Accelerator & incubator | 1 | 6% |
| Other / undisclosed | 5 | 31% |
Recent activity
22 Apr 2026
Event
Combined Otolaryngology Spring Meetings (COSM) 2026
14 Apr 2026
Partnership
Advanced Bionics
5 Aug 2025
Recognition